Stock search

Ticker or company name

Medtronic

MDT · NYSE · Health Care

$102,88Up +0,02 (+0,02%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$133 bn
Div. yield
3,5%
Year to date
+7,1%
52 weeks: $73,31$106,33

Ratio score

78/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

5 ✓ · 4 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM25,127,125,1
Forward P/E15,6—16,2
PEG3,1—2,2
P/S3,53,52,2
EV/EBITDA18,618,817,3
P/FCF21,5—19,5
P/B2,62,33,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 35 analysts

Buy
23
Hold
12
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q1 20271,401,45Up +3,4%
Q4 20261,561,55Down −0,4%
Q3 20261,351,36Up +0,9%
Q2 20261,331,36Up +2,4%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue9,76 bn9,81 bn9,02 bn8,96 bn8,58 bn8,93 bn8,29 bn8,40 bn7,92 bn8,59 bn8,09 bn7,98 bn
EPS1,140,970,891,070,810,821,010,990,800,490,990,68
Margin15,1%12,7%12,7%15,3%12,1%11,8%15,6%15,1%13,2%7,6%16,3%11,4%
FCF1,29 bn2,09 bn2,30 bn457 m584 m2,07 bn2,10 bn554 m466 m2,35 bn2,13 bn200 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $14,7 m.

NameAmountSharesPrice
marinaro michael15 Oct 2026 · sale$1,00 m10 420$96,00
martha geoffrey15 Oct 2026 · sale$4,75 m50 000$95,00
kiil harry skip16 Sep 2026 · sale$138 8831 483$93,65
walter matthew r.8 Jul 2026 · sale$257 9313 102$83,15
kiil harry skip8 Jun 2026 · sale$18 343228$80,45
kiil harry skip8 Jun 2026 · sale$318 6233 961$80,44
kiil harry skip19 Feb 2026 · sale$37 661385$97,82
kiil harry skip19 Feb 2026 · sale$65 347668$97,83
kiil harry skip19 Feb 2026 · sale$1,88 m19 255$97,77
kiil harry skip19 Feb 2026 · sale$2,99 m30 568$97,66
kiil harry skip19 Feb 2026 · sale$161 2731 648$97,86
smith gregory l19 Nov 2025 · sale$51 040500$102,08
smith gregory l19 Nov 2025 · sale$33 170325$102,06
smith gregory l19 Nov 2025 · sale$23 165227$102,05
smith gregory l19 Nov 2025 · sale$84 183825$102,04

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
IE
IPO date
21 Nov 1977

Company description, revenue by segment and region, and the CEO will come later.

Next report
24 Nov 2026

An AI summary of the earnings call will come later.

Peers

CompanyPrice
MCKMcKesson$1 105,0472would consider27,3+8,2%1,1%
SYKStryker Corporation$310,7272would consider33,0+7,9%13,8%
ISRGIntuitive Surgical$437,7583would consider52,0+20,5%25,5%
CVSCVS Health$88,5983would consider10,4+6,7%2,6%
HCAHCA Healthcare$511,7869would watch15,4+5,8%8,6%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.